drugset / Trial / NCT00644748

A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy

NCT00644748

Phase 4 Completed 95 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to evaluate the efficacy, safety, and tolerability of gabapentin for the treatment of patients with painful diabetic neuropathy. The quality of life of all treated patients was also assessed.

Timeline

Start
2003-05
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 3600 mg Oral

Indications